Precision medicine, the growth of biologics and complex therapies are all driving forward the agenda for more complex clinical trials. There seems to be a greater need for sophisticated new technologies and meeting the requirements for complex trials and technologies needs a new approach. When it comes to your clinical research strategy, we need to think and act differently.
It’s about finding the balance between incorporating the newest tools, and developing processes to support the technologies. Learn from the clinical pioneers who have done this, to create overall streamlined, patient centric, successful trials.
Download event brochure to find out more
The event will feature a diverse set of disruptors. Brand new topics and speakers include:
• Adapting your business model - helping patients connect to clinical trials
Robert Kroes, Project Lead, Clinical Open Innovation Europe, Eli Lilly
• Teva’s team success story: Leverage clinical performance excellence by developing an innovative solution
Libby Peer, Associate Director, Head of Business Infrastructure, Clinical Operations, Teva Aviva Egulsky, Senior Director, R&D IT, Teva
• Disrupting traditional paradigms for the development of new biological therapeutics
Jesus Zurdo, Head of Strategic Innovation, Lonza
Places are limited, so book early to avoid disappointment. And remember, pharma manufacturers pay a low rate, so this is a great opportunity to bring your team and share the knowledge.